Leukopenia
Basic details
Preferred term: Leukopenia
Alt. terms: Decreased white blood cell count | Low white blood cell count | Decreased blood leukocyte number
HPO term: Leukopenia
HPO code: HP:0001882
GenIA ID: 52
Last updated on: 2021-12-10 17:55:48
Cross ref. with other ontologies
NCIT: -
MESH: -
EFO: -
OAE: -
SNOMEDCT: -
ICD10: D72.819
Description
An abnormal decreased number of leukocytes in the blood.
Hierarchical classification
Reported patients added to GenIA DB
SubjectID | Sex | Fam.ID | Age* | Population | MatchedTerm | Diagnosis | Reference & Pub.codes |
---|---|---|---|---|---|---|---|
101025 | M | 210937 | 59 | Leukopenia | PMID:34975878 [Fam.F010:P010] | ||
101038 | F | 210182![]() |
- | Caucasian | Leukopenia | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:25329329 [Fam.B:II.6(B.II.4)]; PMID:30250467 [B.II.4]; PMID:29729943 [Fam.B:II.6(B.II.4 (16))]; PMID:34975878 [Fam.F014:III.6(P015)]; PMID:27418640 [P14(5)] |
101045 | M | 210205![]() |
19 | Caucasian | Leukopenia | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:25329329 [Fam.A:III.13(A.III.3)]; PMID:29729943 [Fam.A:III.3(9)]; PMID:34975878 [Fam.F018:III.2(P018)]; PMID:27418640 [P11(5)] |
101049 | F | 210205![]() |
22 | Caucasian | Leukopenia | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:25329329 [Fam.A:III.15(A.III.5)]; PMID:29729943 [Fam.A:III.15(A.III.5 (10))] |
101051 | F | 210205![]() |
30 | Caucasian | Leukopenia | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:25329329 [Fam.A:III.5(A.III.1)]; PMID:30250467 [A.III.1]; PMID:29729943 [Fam.A:III.5(A.III.1 (8))]; PMID:34975878 [Fam.F018:III.1(P021)]; PMID:27418640 [P10(5)] |
101082 | F | 211226 | 48 | Leukopenia | Adenosine deaminase 2 deficiency | PMID:34975878 [Fam.F048:P048] | |
101088 | M | 211560 | 44 | German | Leukopenia | PMID:34975878 [Fam.F054:P054] | |
101091 | M | 210911 | 26 | Leukopenia | DiGeorge syndrome | PMID:34975878 [Fam.F057:P057]; PMID:35486341 [P180] | |
101093 | M | 211289 | 50 | German | Leukopenia | Immunodeficiency, common variable, 8 | PMID:34975878 [Fam.F059:P059]; PMID:31857261 [Patient 4] |
101120 | M | 210221 | 41 | German | Leukopenia | PMID:34975878 [Fam.F071:P071] | |
101129 | F | 210906 | 45 | German | Leukopenia | PMID:34975878 [Fam.F078:P078] | |
101132 | M | 210304 | - | German | Leukopenia | PMID:34975878 [Fam.F081:P081] | |
101133 | M | 210896 | 40 | Leukopenia | Immunodeficiency, common variable, 13 | PMID:34975878 [Fam.F082:P082] | |
101312 | M | 212149 | 7 | Lebanese | Leukopenia | Immunodeficiency, common variable, 8 | PMID:25468195 [Fam.B:II.1(P2)]; PMID:26707784 [P16] |
101399 | F | 210189![]() |
16 | German | Leukopenia | Adenosine deaminase 2 deficiency | PMID:28493328 [P6]; PMID:26922074 [Fam.Index:II.1(sister1)] |
101404 | M | 210348 | 19 | Leukopenia | PMID:34975878 [Fam.F139:P139] | ||
101479 | F | 210314![]() |
- | German | Leukopenia | NFKB1 insufficiency | PMID:34975878 [Fam.F160:P160]; PMID:32278790 [Fam.BF:II.2(II.2)]; PMID:29403474 [Fam.(13):II.1(Patient 2)]; PMID:27923702 [Fam.191:II.1(Patient 2)]; PMID:150198 [Fam.AO:II.2(164)]; GRID:001142 [Fam.#:II.2(FR036)] |
101613 | F | 210737 | 13 | Leukopenia | PMID:34975878 [Fam.F210:P210] | ||
101620 | M | 211003 | 11 | Leukopenia | PMID:34975878 [Fam.F214:P214] | ||
101884 | M | 212237![]() |
- | Sudanese | Leukopenia | Hyper-IgE recurrent infection syndrome 3 | PMID:29907690 [Fam.A:III.3(A.II.3)] |
101913 | M | 211925 | - | Leukopenia | PMID:34975878 [Fam.F340:P340] | ||
102133 | M | 214352![]() |
- | Sudanese | Leukopenia | Hyper-IgE recurrent infection syndrome 3 | PMID:29907690 [Fam.C:II.1(C.II.1)] |
102207 | M | 214915![]() |
61 | Leukopenia | Tubulointerstitial kidney disease type 5 | PMID:27392076 [Fam.2:II.2(II:2)] | |
102209 | F | 214915![]() |
27 | Leukopenia | Tubulointerstitial kidney disease type 5 | PMID:27392076 [Fam.2:III.1(III:1)] | |
102421 | M | 214949![]() |
15 | French | Leukopenia | Hyper-IgE recurrent infection syndrome 4A | PMID:32207811 [Fam.A:III.1(P3)] |
102641 | M | 214973![]() |
- | European | Leukopenia | Immunodeficiency 98 with autoinflammation, somatic | PMID:33512449 [Fam.5:II.2(P5)] |
102786 | F | 214988![]() |
23 | Turkish | Leukopenia | Hyper-IgE recurrent infection syndrome 3 | PMID:29907691 [Fam.D:II.1(P6)] |
102803 | F | 214991![]() |
15 | North American | Leukopenia | Immunodeficiency 8 | PMID:25073507 [P1(II.2)] |
102814 | U | 214993![]() |
1 | Caucasian | Leukopenia | SCID with microcephaly, growth retardation, and sensitivity to ionizing radiation | PMID:16439205 [Patient]; PMID:12604777 [2BN(II.1)] |
102818 | M | 214993![]() |
4 | Caucasian | Leukopenia | SCID with microcephaly, growth retardation, and sensitivity to ionizing radiation | PMID:12604777 [Fam.2BN:II.2(3BN)] |
103113 | M | 215100![]() |
2 | Iranian | Leukopenia | Seizures, cortical blindness, microcephaly syndrome | PMID:36212620 [Patient(II.1)] |
103281 | F | 215111![]() |
2 | Chinese (China) | Leukopenia | Immunodeficiency 82 with systemic inflammation | PMID:33782605 [Fam.1:II.2(P1)] |
103286 | M | 215112![]() |
2 | Ashkenazi Jewish | Leukopenia | Immunodeficiency 82 with systemic inflammation | PMID:33782605 [Fam.2:I.1(P3)] |
103834 | F | 215257![]() |
- | European | Leukopenia | Adenosine deaminase 2 deficiency | PMID:24552284 [Fam.2:II.3(P2)] |
103839 | M | 215258![]() |
- | European | Leukopenia | Adenosine deaminase 2 deficiency | PMID:24552284 [Fam.3:II.3(P3)] |
103844 | F | 215259![]() |
- | European | Leukopenia | Adenosine deaminase 2 deficiency | PMID:24552284 [Fam.4:II.2(P4)] |
103848 | M | 215260![]() |
- | European | Leukopenia | Adenosine deaminase 2 deficiency | PMID:24552284 [Fam.5:II.1(P5)] |
103859 | M | 215263![]() |
- | Turkish | Leukopenia | Adenosine deaminase 2 deficiency | PMID:24552284 [Fam.8:II.1(P9)]; PMID:26233953 [Fam.F4:P5] |
104307 | F | 215451![]() |
17 | North American | Leukopenia | Hyper-IgE recurrent infection syndrome 1 | PMID:19483664 [Patient(II.1)]; PMID:26292779 [Co2] |
105093 | F | 215639![]() |
- | Israeli | Leukopenia | NFKB1 insufficiency | PMID:32278790 [Fam.AA:II.2(II.2)]; PMID:29403474 [Patient 2 (8)]; PMID:27365489 [Fam.2:II.2(Pat.2)]; PMID:150198 [Fam.AF:II.2(127)] |
105105 | F | 215643![]() |
15 | Caucasian | Leukopenia | NFKB1 insufficiency | PMID:32278790 [Fam.AB:II.1(II.1)]; PMID:29403474 [Fam.(7):II.1(Index)]; PMID:27338827 [Fam.1:II.1(II-1)]; PMID:150198 [Fam.AD:II.1(117)] |
105225 | F | 215671![]() |
- | Finnish | Leukopenia | NFKB1 insufficiency | PMID:32278790 [Fam.F2:II.2(II.2)]; PMID:29403474 [Fam.2 (9):II.3(F2.II-3)]; PMID:28115215 [Fam.2:II.3(F2.II-3)]; PMID:150198 [Fam.AR:II.3(191)]; PMID:36356849 [Fam.5:II.2(F5:II:2)] |
105251 | M | 215678 | - | Leukopenia | Combined immunodeficiency 36 | PMID:33876203 [P1(II.1)] | |
105363 | F | 215722 | 13 | Afro-American | Leukopenia | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.X:II.1(X.II.1 (59))]; PMID:28366794 [Fam.A:II.1(P1)] |
105412 | F | 215762![]() |
27 | Caucasian | Leukopenia | NFKB1 insufficiency | PMID:32278790 [Fam.BB:I.1(I.1)]; PMID:30063981 [Fam.1:II.2(II.2)]; PMID:150198 [Fam.BM:II.3(300)] |
105549 | F | 215801 | 12 | Caucasian | Leukopenia | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29200144 [Fam.A:IV.1(P1)] |
105746 | M | 215851![]() |
57 | Finnish | Leukopenia | Immunodeficiency, common variable, 14 | PMID:34451894 [Patient(II.2)]; PMID:37876937 [Fam.C:II.2(C.1)] |
105899 | F | 215900![]() |
- | North American | Leukopenia | NFKB1 insufficiency | PMID:150198 [Fam.DW:II.1(538)]; PMID:34307247 [Fam.1:II.1(daughter1)]; PMID:28802957 [Fam.1:II.1(II.1)] |
106109 | M | 215952![]() |
4 | Iranian | Leukopenia | NFKB1 insufficiency | PMID:150198 [Fam.EG:III.4(584)]; PMID:35392793 [Fam.1:III.4(III-1(index))] |
106165 | M | 215964 | - | Turkish | Leukopenia | Immunodeficiency, common variable, 8 | PMID:31432443 [P9] |
106172 | F | 215971 | - | German | Leukopenia | NFKB1 insufficiency | PMID:150198 [Fam.FI:660]; GRID:001142 [FR302] |
106223 | M | 215976![]() |
- | Finnish | Leukopenia | NFKB1 insufficiency | PMID:150198 [Fam.FN:II.1(710)]; PMID:36356849 [Fam.4:II.1(F4:II:1)]; PMID:38593810 [Fam.3:II.1(F3.II-1)] |
106358 | M | 216000 | 19 | Leukopenia | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:31993940 [Patient(II.1)] | |
106363 | F | 216001![]() |
0 | Argentinian | Leukopenia | Immunodeficiency 117 | PMID:36736301 [Fam.A:II.1(P1)] |
106371 | M | 216004 | 17 | Leukopenia | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29375547 [Fam.A:II.1(A.II.1)]; PMID:31396201 [P2(II.1)] | |
106423 | F | 216015![]() |
9 | Leukopenia | NFKB1 insufficiency | PMID:150198 [Fam.FU:III.4(765)]; PMID:38130541 [Fam.1:III.4(P1)] | |
106760 | M | 216123![]() |
0 | Israeli | Leukopenia | X-linked severe combined immunodeficiency | PMID:32921793 [Fam.A:II.1(P1-A)] |
106819 | M | 216163![]() |
48 | Chinese (China) | Leukopenia | Immunodeficiency, common variable, 1 | PMID:36571238 [Fam.2:II.2(II:2[P3])] |
106854 | F | 216173![]() |
1 | Caucasian | Leukopenia | Adenosine deaminase 2 deficiency | PMID:31008556 [Fam.5:II.1(P5)] |
107225 | M | 216381![]() |
0 | Vietnamese | Leukopenia | Hemophagocytic lymphohistiocytosis, familial 5 | PMID:36503158 [Patient(III.3)] |
*Age: age reported at the first known time of manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).